Cardiovascular Surgery Clinical Trial
Official title:
A Randomised, Open Label, Parallel-group, Multi-centre Trial to Compare the Efficacy and Safety of TachoSil® Versus Standard Haemostatic Treatment in Cardiovascular Surgery
Verified date | July 2010 |
Source | Nycomed |
Contact | n/a |
Is FDA regulated | No |
Health authority | Germany: Paul-Ehrlich-Institut |
Study type | Interventional |
To demonstrate efficacy and safety of TachoSil® in cardiovascular surgery
Status | Completed |
Enrollment | 120 |
Est. completion date | November 2007 |
Est. primary completion date | August 2007 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: All inclusion criteria must be answered "yes" for a subject to participate in the trial. At Screening: 1. Has the subject given informed consent according to local requirements before any trial related activities? A trial related activity is any procedure that would not have been performed during the routine management of the subject. In this trial the screening is the first trial related activity. 2. For female subjects of childbearing potential: Is the pregnancy test at screening negative? 3. Does the female subject of childbearing potential use adequate contraception (contraceptive pill, contraceptive injection, contraceptive implant or intrauterine device)? 4. Is the subject = 18 years of age? 5. Is the following planned: An elective surgery on the heart, the ascending aorta or arch, requiring cardiopulmonary bypass procedure? Intra operative (after primary haemostatic treatment): 6. Is bleeding from the heart muscle, the pericardium, a major vessel or a vascular bed that requires supportive haemostatic treatment present? 7. Has the area with the most problematic haemorrhage (target area) been identified? (please note that this must be done before randomisation). 8. Is it possible to compress the randomised treatment (TachoSil® or control fleece material) for 3 minutes? Exclusion Criteria: All exclusion criteria must be answered "no" for a subject to participate in the trial. At Screening: 1. Has the subject participated in any other trial with an investigational drug or device within 30 days before inclusion in this trial? 2. Does the subject participate in a clinical trial concomitantly with the present trial? 3. Is the subject undergoing an emergency operation? 4. Has the subject a history of allergic reactions after application of human fibrinogen, human thrombin and/or collagen of any origin? 5. Is the subject suffering from known coagulopathy? 6. Is the subject currently participating or has the subject previously participated in the TC-023-IM trial? 7. Is the female subject pregnant or breast feeding? Intra operative (after primary haemostatic treatment): 8. Has liquid fibrin sealant/glue or TachoSil® been applied? 9. Has the following occurred: Disseminated intravascular coagulation (DIC), i.e. micro vascular bleeding? |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Denmark | Nycomed | Roskilde |
Lead Sponsor | Collaborator |
---|---|
Nycomed |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of Subjects Achieving Haemostasis at 3 Minutes | Three minutes after application of trial treatment (TachoSil® or standard fleece material) the investigator evaluated if haemostasis in the target area was achieved. | 3 minutes | Yes |
Secondary | Proportion of Subjects Achieving Haemostasis at 6 Minutes. | Six minutes after application of trial treatment (TachoSil® or standard fleece material) the investigator evaluated if haemostasis in the target area was achieved. | 6 minutes | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02203968 -
Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST)
|
Phase 1/Phase 2 | |
Recruiting |
NCT06097637 -
Underwater Endoscopic Mucosal Resection Versus Metal Clips With Hot Snare Polypectomy for Resection of Big Pedunculated Colorectal Polyps:a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT06097650 -
Cold Snare Polypectomy Versus Hot Snare Polypectomy for Resection of Small Pedunculated Colorectal Polyps:a Randomized Controlled Trial
|
N/A | |
Completed |
NCT01938768 -
Effects of an Early Prehospital Administration of Tranexamic Acid on Hyperfibrinolysis in Multiple Trauma
|
N/A | |
Completed |
NCT02765022 -
Clip Closure of Mucosal Defects After Endoscopic Mucosal Resection.
|
N/A | |
Completed |
NCT01629381 -
Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy
|
Phase 2 | |
Terminated |
NCT01961804 -
PREVACT : Preventive REversal of Vitamine K Antagonist in Minor Craniocerebral Trauma
|
Phase 3 | |
Completed |
NCT02106000 -
A Non-investigational Product (IP) Study to Investigate Lung Function in Women in the Third Stage of Labour
|
N/A | |
Completed |
NCT02480556 -
Comparing Blood Loss During Caesarean Section Between Manual Separation of Placenta & Conservative Management
|
N/A | |
Completed |
NCT02344069 -
Pilot Randomized Trial of Fibrinogen in Trauma Haemorrhage
|
Phase 2 | |
Completed |
NCT02745041 -
Fibrinogen Early In Severe Trauma studY
|
Phase 2 |